Predictors of pregnancy in women with polycystic ovary syndrome
- PMID: 19509098
- PMCID: PMC2741722
- DOI: 10.1210/jc.2009-0545
Predictors of pregnancy in women with polycystic ovary syndrome
Abstract
Context: Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility. The selection of first-line therapies for ovulation induction is empiric.
Objective: The aim of the study was to develop a clinically useful predictive model of live birth with varying ovulation induction methods.
Design, setting, and participants: We built four prognostic models from a large multicenter randomized controlled infertility trial of 626 women with PCOS performed at academic health centers in the United States to predict success of ovulation, conception, pregnancy, and live birth, evaluating the influence of patients' baseline characteristics.
Interventions: Ovulation was induced with clomiphene, metformin, or the combination of both for up to six cycles or conception.
Main outcome measure: The primary outcome of the trial was the rate of live births.
Results: Baseline free androgen index, baseline proinsulin level, interaction of treatment arm with body mass index, and duration of attempting conception were significant predictors in all four models. History of a prior loss predicted ovulation and conception, but not pregnancy or live birth. A modified Ferriman Gallwey hirsutism score of less than 8 was predictive of conception, pregnancy, and live birth (although it did not predict ovulation success). Age was a divergent predictor based on outcome; age greater than 34 predicted ovulation, whereas age less than 35 was a predictive factor for a successful pregnancy and live birth. Smoking history had no predictive value.
Conclusions: A live birth prediction chart developed from basic clinical parameters (body mass index, age, hirsutism score, and duration of attempting conception) may help physicians counsel and select infertility treatments for women with PCOS.
Trial registration: ClinicalTrials.gov NCT00068861.
Figures

Comment in
-
Predicting pregnancy in women with polycystic ovary syndrome.J Clin Endocrinol Metab. 2009 Sep;94(9):3183-4. doi: 10.1210/jc.2009-1537. J Clin Endocrinol Metab. 2009. PMID: 19734445 No abstract available.
Similar articles
-
Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.Hum Reprod. 2015 Sep;30(9):2222-33. doi: 10.1093/humrep/dev182. Epub 2015 Jul 22. Hum Reprod. 2015. PMID: 26202922 Free PMC article.
-
Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome.Obstet Gynecol. 2012 May;119(5):902-8. doi: 10.1097/AOG.0b013e31824da35c. Obstet Gynecol. 2012. PMID: 22525900 Free PMC article. Clinical Trial.
-
First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.Hum Reprod Update. 2019 Nov 5;25(6):717-732. doi: 10.1093/humupd/dmz029. Hum Reprod Update. 2019. PMID: 31647106
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2. Endocr Pract. 2015. PMID: 26642102 Review.
-
Ovulation induction in women with polycystic ovary syndrome.Steroids. 2013 Aug;78(8):767-72. doi: 10.1016/j.steroids.2013.05.005. Epub 2013 May 21. Steroids. 2013. PMID: 23707553 Review.
Cited by
-
Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.Hum Reprod. 2015 Sep;30(9):2222-33. doi: 10.1093/humrep/dev182. Epub 2015 Jul 22. Hum Reprod. 2015. PMID: 26202922 Free PMC article.
-
Welsh Onion Root (Allium fistulosum) Restores Ovarian Functions from Letrozole Induced-Polycystic Ovary Syndrome.Nutrients. 2018 Oct 4;10(10):1430. doi: 10.3390/nu10101430. Nutrients. 2018. PMID: 30287740 Free PMC article.
-
For what reasons should metformin be used in the management of polycystic ovary syndrome?J Endocrinol Invest. 2012 Jan;35(1):87-9. doi: 10.3275/8195. Epub 2011 Dec 21. J Endocrinol Invest. 2012. PMID: 22189518 No abstract available.
-
Obesity and PCOS: implications for diagnosis and treatment.Semin Reprod Med. 2012 Dec;30(6):496-506. doi: 10.1055/s-0032-1328878. Epub 2012 Oct 16. Semin Reprod Med. 2012. PMID: 23074008 Free PMC article. Review.
-
Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.Nat Commun. 2024 Jul 4;15(1):5591. doi: 10.1038/s41467-024-49749-1. Nat Commun. 2024. PMID: 38965226 Free PMC article.
References
-
- Hull MG 1987 Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1:235–245 - PubMed
-
- Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745–2749 - PubMed
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25 - PubMed
-
- The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47 - PubMed
-
- Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223–1236 - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- U10 HD038988/HD/NICHD NIH HHS/United States
- U10 HD039005/HD/NICHD NIH HHS/United States
- U10 HD27049/HD/NICHD NIH HHS/United States
- C06 RR016499/RR/NCRR NIH HHS/United States
- MO1RR10732/RR/NCRR NIH HHS/United States
- U54-HD29834/HD/NICHD NIH HHS/United States
- U10 HD038999/HD/NICHD NIH HHS/United States
- U10 HD033172/HD/NICHD NIH HHS/United States
- R01 HD029834/HD/NICHD NIH HHS/United States
- U10 HD027049/HD/NICHD NIH HHS/United States
- U10 HD27011/HD/NICHD NIH HHS/United States
- U10 HD027011/HD/NICHD NIH HHS/United States
- U01 HD38997/HD/NICHD NIH HHS/United States
- M01 RR010732/RR/NCRR NIH HHS/United States
- MO1RR00056/RR/NCRR NIH HHS/United States
- U10 HD33172/HD/NICHD NIH HHS/United States
- M01 RR000056/RR/NCRR NIH HHS/United States
- U10 HD38998/HD/NICHD NIH HHS/United States
- U10 HD038998/HD/NICHD NIH HHS/United States
- U10 HD39005/HD/NICHD NIH HHS/United States
- U10 HD038992/HD/NICHD NIH HHS/United States
- U10 HD38992/HD/NICHD NIH HHS/United States
- U10 HD38999/HD/NICHD NIH HHS/United States
- U01 HD038997/HD/NICHD NIH HHS/United States
- U10 HD38988/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical